Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Roivant Sciences Ltd.SHS(ROIV) | 2,800,000 | 3,750,000 | +950,000 | $77.56M | $132.71M | 6.49% | +$55.15M |
| Apogee Therapeutics Inc | 1,284,926 | 987,000 | -297,926 | $108.15M | $131.00M | 6.41% | +$22.85M |
| Spyre Therapeutics, Inc.(SYRE) | 1,279,134 | 1,279,134 | 0 | $64.52M | $113.56M | 5.55% | +$49.04M |
| Xenon Pharmaceuticals Inc.(XENE) | 1,675,000 | 1,595,000 | -80,000 | $97.40M | $96.27M | 4.71% | -$1.13M |
| Erasca, Inc.(ERAS) | 5,350,000 | 5,250,000 | -100,000 | $86.56M | $96.18M | 4.70% | +$9.62M |
| Insmed Incorporated(INSM) | 480,000 | 650,000 | +170,000 | $78.49M | $69.30M | 3.39% | -$9.19M |
| Praxis Precision Medicines, Inc.(PRAX) | 170,000 | 185,000 | +15,000 | $54.77M | $61.94M | 3.03% | +$7.16M |
| Alkermes plcSHS(ALKS) | 1,350,000 | 1,125,000 | -225,000 | $47.74M | $58.94M | 2.88% | +$11.21M |
| Oruka Therapeutics, Inc.(ORKA) | 499,673 | 590,000 | +90,327 | $24.51M | $56.15M | 2.75% | +$31.64M |
| Anaptysbio Inc | 940,000 | 826,109 | -113,891 | $52.13M | $55.76M | 2.73% | +$3.63M |
| Avalo Therapeutics, Inc.(AVTX) | 1,340,840 | 2,900,000 | +1,559,160 | $20.02M | $53.59M | 2.62% | +$33.57M |
| Cytokinetics, Incorporated(CYTK) | 700,483 | 550,000 | -150,483 | $46.17M | $46.85M | 2.29% | +$685.7K |
| Revolution Medicines, Inc.(RVMD) | 100,000 | 250,000 | +150,000 | $9.72M | $46.82M | 2.29% | +$37.09M |
| ABIVAX Société AnonymeADS(ABVX) | 405,000 | 330,000 | -75,000 | $45.10M | $43.98M | 2.15% | -$1.12M |
| First Tracks Biotherapeutics | 0 | 2,032,012 | +2,032,012 | $0 | $40.88M | 2.00% | +$40.88M |
| Dianthus Therapeutics, Inc.(DNTH) | 350,000 | 400,000 | +50,000 | $29.37M | $38.99M | 1.91% | +$9.62M |
| Sutro Biopharma, Inc.(STRO) | 1,069,519 | 1,172,487 | +102,968 | $26.64M | $38.93M | 1.90% | +$12.28M |
| Nuvalent Inc | 300,000 | 275,000 | -25,000 | $30.73M | $33.96M | 1.66% | +$3.23M |
| Trevi Therapeutics, Inc.(TRVI) | 2,000,172 | 1,800,172 | -200,000 | $23.86M | $33.57M | 1.64% | +$9.71M |
| Ovid Therapeutics Inc.(OVID) | 10,636,318 | 10,144,562 | -491,756 | $23.61M | $27.29M | 1.33% | +$3.68M |
| Lexeo Therapeutics, Inc.(LXEO) | 5,050,211 | 5,807,611 | +757,400 | $28.99M | $27.03M | 1.32% | -$1.95M |
| Celldex Therapeutics, Inc.(CLDX) | 500,000 | 700,000 | +200,000 | $15.86M | $26.05M | 1.27% | +$10.19M |
| Belite Bio, IncADS(BLTE) | 65,000 | 165,000 | +100,000 | $10.36M | $25.41M | 1.24% | +$15.04M |
| Enliven Therapeutics Inc | 586,904 | 500,000 | -86,904 | $23.01M | $25.38M | 1.24% | +$2.37M |
| Forte Biosciences Inc | 1,011,890 | 1,145,391 | +133,501 | $26.21M | $24.34M | 1.19% | -$1.87M |
| Nurix Therapeutics, Inc.(NRIX) | 967,620 | 967,620 | 0 | $15.00M | $23.47M | 1.15% | +$8.48M |
| Alto Neuroscience, Inc.(ANRO) | 500,000 | 850,000 | +350,000 | $11.24M | $22.43M | 1.10% | +$11.19M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 55,000 | 40,000 | -15,000 | $28.79M | $21.48M | 1.05% | -$7.31M |
| Protagonist Therapeutics Inc | 172,125 | 172,125 | 0 | $18.14M | $21.10M | 1.03% | +$2.96M |
| Mineralys Therapeutics, Inc.(MLYS) | 750,000 | 750,000 | 0 | $20.32M | $20.23M | 0.99% | -$82.5K |
| Relay Therapeutics, Inc.(RLAY) | 400,000 | 1,050,000 | +650,000 | $3.98M | $19.65M | 0.96% | +$15.67M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 868,020 | 2,497,864 | +1,629,844 | $4.54M | $19.31M | 0.94% | +$14.77M |
| Jade Biosciences Inc | 639,956 | 840,350 | +200,394 | $8.99M | $18.67M | 0.91% | +$9.68M |
| Cogent Biosciences, Inc.(COGT) | 750,000 | 450,000 | -300,000 | $28.87M | $17.41M | 0.85% | -$11.45M |
| Travere Therapeutics, Inc.(TVTX) | 300,000 | 300,000 | 0 | $8.91M | $17.04M | 0.83% | +$8.13M |
| Cullinan Therapeutics, Inc.(CGEM) | 781,260 | 875,760 | +94,500 | $11.10M | $15.95M | 0.78% | +$4.85M |
| Savara Inc.(SVRA) | 2,512,153 | 2,512,153 | 0 | $13.72M | $15.47M | 0.76% | +$1.76M |
| IDEAYA Biosciences, Inc.(IDYA) | 0 | 400,000 | +400,000 | $0 | $14.91M | 0.73% | +$14.91M |
| Perspective Therapeutics, Inc.(CATX) | 3,164,582 | 4,214,582 | +1,050,000 | $13.20M | $14.37M | 0.70% | +$1.18M |
| Odyssey Therapeutics Inc | 0 | 766,346 | +766,346 | $0 | $14.34M | 0.70% | +$14.34M |
| Cogent Biosciences, Inc.NOTE 1 625 11 1(COGT) | 0 | 0 | 0 | $8.59M | $13.65M | 0.67% | +$5.07M |
| Helix Acquisition Corp. IIICL A(HLXC) | 1,250,000 | 1,250,000 | 0 | $12.70M | $13.30M | 0.65% | +$600.0K |
| Equillium, Inc.(EQ) | 1,226,310 | 4,100,000 | +2,873,690 | $2.45M | $13.12M | 0.64% | +$10.67M |
| Establishment Labs Holdings Inc.(ESTA) | 100,000 | 148,013 | +48,013 | $5.68M | $12.70M | 0.62% | +$7.02M |
| Climb Bio, Inc.(CLYM) | 700,000 | 972,000 | +272,000 | $4.79M | $12.67M | 0.62% | +$7.88M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,400,000 | 374,000 | -1,026,000 | $42.17M | $12.67M | 0.62% | -$29.50M |
| Veradermics, Incorporated(MANE) | 70,000 | 100,000 | +30,000 | $4.42M | $12.29M | 0.60% | +$7.87M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 200,000 | 150,000 | -50,000 | $12.54M | $12.23M | 0.60% | -$313.5K |
| Omeros CorporationNOTE 9 500 6 1(OMER) | 0 | 0 | 0 | $13.22M | $12.18M | 0.60% | -$1.04M |
| Taysha Gene Therapies, Inc.(TSHA) | 1,000,000 | 1,750,000 | +750,000 | $4.47M | $11.92M | 0.58% | +$7.45M |
| Damora Therapeutics, Inc.(DMRA) | 450,000 | 425,000 | -25,000 | $11.65M | $11.05M | 0.54% | -$600.8K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 1,589,005 | 1,650,000 | +60,995 | $11.50M | $10.91M | 0.53% | -$597.9K |
| Vera Therapeutics, Inc.CL A(VERA) | 250,000 | 250,000 | 0 | $10.06M | $10.73M | 0.52% | +$670.0K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 2,454,278 | 5,543,936 | +3,089,658 | $3.98M | $10.31M | 0.50% | +$6.34M |
| Newamsterdam Pharma Company ORDINARY SHARES | 275,000 | 275,000 | 0 | $8.80M | $9.32M | 0.46% | +$517.0K |
| Korro Bio, Inc.(KRRO) | 706,904 | 706,904 | 0 | $8.00M | $9.32M | 0.46% | +$1.31M |
| Anteris Technologies Global Corp.(AVR) | 912,397 | 912,397 | 0 | $5.06M | $8.99M | 0.44% | +$3.92M |
| Zura Bio LimitedCL A(ZURA) | 2,564,303 | 1,464,303 | -1,100,000 | $15.26M | $8.64M | 0.42% | -$6.62M |
| uniQure N.V.SHS(QURE) | 0 | 175,000 | +175,000 | $0 | $8.06M | 0.39% | +$8.06M |
| Ascendis Pharma A/S(ASND) | 0 | 30,000 | +30,000 | $0 | $8.00M | 0.39% | +$8.00M |
| iBio, Inc.(IBIO) | 3,107,200 | 4,007,881 | +900,681 | $5.90M | $7.01M | 0.34% | +$1.11M |
| Generate Biomedicines, Inc.(GENB) | 350,000 | 400,000 | +50,000 | $4.38M | $6.75M | 0.33% | +$2.37M |
| Tyra Biosciences, Inc.(TYRA) | 257,512 | 200,012 | -57,500 | $9.86M | $6.39M | 0.31% | -$3.47M |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 35,000 | 84,900 | +49,900 | $2.77M | $6.29M | 0.31% | +$3.52M |
| SAB Biotherapeutics, Inc.(SABS) | 575,000 | 1,525,000 | +950,000 | $2.20M | $5.95M | 0.29% | +$3.75M |
| MacroGenics, Inc.(MGNX) | 500,000 | 1,216,606 | +716,606 | $1.45M | $5.62M | 0.27% | +$4.18M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 150,000 | 100,000 | -50,000 | $7.14M | $5.45M | 0.27% | -$1.68M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 245,000 | 245,000 | 0 | $4.91M | $5.34M | 0.26% | +$433.6K |
| Assembly Biosciences Inc | 0 | 190,000 | +190,000 | $0 | $5.22M | 0.26% | +$5.22M |
| Rezolute, Inc.(RZLT) | 1,547,641 | 1,000,000 | -547,641 | $4.72M | $5.20M | 0.25% | +$479.7K |
| Precision BioSciences, Inc.(DTIL) | 597,946 | 646,576 | +48,630 | $3.29M | $5.08M | 0.25% | +$1.79M |
| Hemab Therapeutics Hldgs Inc | 0 | 138,030 | +138,030 | $0 | $5.07M | 0.25% | +$5.07M |
| Viridian Therapeutics, Inc.(VRDN) | 250,000 | 250,000 | 0 | $4.89M | $4.59M | 0.22% | -$297.5K |
| ArriVent BioPharma, Inc.(AVBP) | 175,000 | 125,000 | -50,000 | $4.04M | $4.34M | 0.21% | +$305.3K |
| Verrica Pharmaceuticals Inc.(VRCA) | 707,338 | 707,338 | 0 | $3.74M | $4.33M | 0.21% | +$587.1K |
| COMPASS Pathways plcADS(CMPS) | 1,108,483 | 301,183 | -807,300 | $6.13M | $4.26M | 0.21% | -$1.87M |
| MBX Biosciences, Inc.(MBX) | 150,000 | 75,000 | -75,000 | $4.48M | $4.14M | 0.20% | -$337.5K |
| Research Alliance Corp IiiCL A | 0 | 370,000 | +370,000 | $0 | $3.96M | 0.19% | +$3.96M |
| Immunovant, Inc.(IMVT) | 100,000 | 100,000 | 0 | $2.48M | $3.85M | 0.19% | +$1.37M |
| Amanat Acquisition CorpCL A | 0 | 375,000 | +375,000 | $0 | $3.81M | 0.19% | +$3.81M |
| Biohaven Ltd.(BHVN) | 0 | 250,000 | +250,000 | $0 | $3.72M | 0.18% | +$3.72M |
| Faeth Therapeutics, Inc.(FTH) | 0 | 144,404 | +144,404 | $0 | $3.61M | 0.18% | +$3.61M |
| Karyopharm Therapeutics Inc.(KPTI) | 500,000 | 312,500 | -187,500 | $2.79M | $3.05M | 0.15% | +$268.1K |
| Alector Inc | 500,000 | 1,510,000 | +1,010,000 | $1.07M | $3.04M | 0.15% | +$1.96M |
| SpyGlass Pharma, Inc.(SGP) | 250,000 | 131,586 | -118,414 | $6.48M | $2.93M | 0.14% | -$3.55M |
| Crinetics Pharmaceuticals In | 75,000 | 75,000 | 0 | $2.72M | $2.81M | 0.14% | +$82.5K |
| Oaktree Acquisition Corp IiiUNIT 10 04 2029 UNIT 10/04/2029 | 250,000 | 250,000 | 0 | $2.66M | $2.75M | 0.13% | +$87.5K |
| Celcuity IncNOTE 0 250 8 0 | 0 | 0 | 0 | $0 | $2.28M | 0.11% | +$2.28M |
| Jatt Ii Acquisition Corp | 0 | 200,000 | +200,000 | $0 | $2.27M | 0.11% | +$2.27M |
| Neumora Therapeutics, Inc.(NMRA) | 0 | 1,070,651 | +1,070,651 | $0 | $1.82M | 0.09% | +$1.82M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 0 | 98,999 | +98,999 | $0 | $1.78M | 0.09% | +$1.78M |
| Adlai Nortye Group Ltd.ADS(ANL) | 164,748 | 153,847 | -10,901 | $1.14M | $1.77M | 0.09% | +$629.2K |
| Spruce Biosciences Inc | 0 | 30,000 | +30,000 | $0 | $1.62M | 0.08% | +$1.62M |
| Eikon Therapeutics, Inc.(EIKN) | 0 | 98,001 | +98,001 | $0 | $1.28M | 0.06% | +$1.28M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 240,963 | 240,963 | 0 | $997.6K | $1.10M | 0.05% | +$101.2K |
| enGene Therapeutics Inc.(ENGN) | 0 | 600,000 | +600,000 | $0 | $1.04M | 0.05% | +$1.04M |
| X4 Pharmaceuticals, Inc.(XFOR) | 145,000 | 145,000 | 0 | $598.9K | $677.1K | 0.03% | +$78.3K |
| Boundless Bio, Inc.(BOLD) | 0 | 250,000 | +250,000 | $0 | $625.0K | 0.03% | +$625.0K |
| LENZ Therapeutics, Inc.(LENZ) | 100,000 | 100,000 | 0 | $915.0K | $568.0K | 0.03% | -$347.0K |
| Q32 Bio Inc.(QTTB) | 27,777 | 27,777 | 0 | $178.3K | $353.9K | 0.02% | +$175.6K |